BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32651586)

  • 21. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
    Heininger U
    Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
    [No Abstract]   [Full Text] [Related]  

  • 22. Animal models for COVID-19.
    Muñoz-Fontela C; Dowling WE; Funnell SGP; Gsell PS; Riveros-Balta AX; Albrecht RA; Andersen H; Baric RS; Carroll MW; Cavaleri M; Qin C; Crozier I; Dallmeier K; de Waal L; de Wit E; Delang L; Dohm E; Duprex WP; Falzarano D; Finch CL; Frieman MB; Graham BS; Gralinski LE; Guilfoyle K; Haagmans BL; Hamilton GA; Hartman AL; Herfst S; Kaptein SJF; Klimstra WB; Knezevic I; Krause PR; Kuhn JH; Le Grand R; Lewis MG; Liu WC; Maisonnasse P; McElroy AK; Munster V; Oreshkova N; Rasmussen AL; Rocha-Pereira J; Rockx B; Rodríguez E; Rogers TF; Salguero FJ; Schotsaert M; Stittelaar KJ; Thibaut HJ; Tseng CT; Vergara-Alert J; Beer M; Brasel T; Chan JFW; García-Sastre A; Neyts J; Perlman S; Reed DS; Richt JA; Roy CJ; Segalés J; Vasan SS; Henao-Restrepo AM; Barouch DH
    Nature; 2020 Oct; 586(7830):509-515. PubMed ID: 32967005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The COVID-19 vaccine development landscape.
    Thanh Le T; Andreadakis Z; Kumar A; Gómez Román R; Tollefsen S; Saville M; Mayhew S
    Nat Rev Drug Discov; 2020 May; 19(5):305-306. PubMed ID: 32273591
    [No Abstract]   [Full Text] [Related]  

  • 24. COVID-19: Small-Molecule Clinical Trials Landscape.
    Ferreira LLG; Andricopulo AD
    Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
    [No Abstract]   [Full Text] [Related]  

  • 25. Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!
    Boudjelal M; Nehdi A; Islam I
    Expert Opin Drug Discov; 2020 Nov; 15(11):1233-1235. PubMed ID: 32543297
    [No Abstract]   [Full Text] [Related]  

  • 26. COVID-19 shot protects monkeys.
    Cohen J
    Science; 2020 May; 368(6490):456-457. PubMed ID: 32355008
    [No Abstract]   [Full Text] [Related]  

  • 27. Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19.
    Dong H
    Cancer Immunol Immunother; 2020 Jun; 69(6):911-912. PubMed ID: 32347359
    [No Abstract]   [Full Text] [Related]  

  • 28. SARS-CoV-2: A New Song Recalls an Old Melody.
    Subbarao K
    Cell Host Microbe; 2020 May; 27(5):692-694. PubMed ID: 32407706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fast-and-fit vaccines.
    Nat Biomed Eng; 2020 Aug; 4(8):757-758. PubMed ID: 32760006
    [No Abstract]   [Full Text] [Related]  

  • 30. All eyes on a hurdle race for a SARS-CoV-2 vaccine.
    Gaebler C; Nussenzweig MC
    Nature; 2020 Oct; 586(7830):501-502. PubMed ID: 33077943
    [No Abstract]   [Full Text] [Related]  

  • 31. Current development of COVID-19 diagnostics, vaccines and therapeutics.
    Zhang N; Li C; Hu Y; Li K; Liang J; Wang L; Du L; Jiang S
    Microbes Infect; 2020; 22(6-7):231-235. PubMed ID: 32387332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus: The other invisible enemy.
    Abel MK; Huh WK; Chan JK
    Gynecol Oncol; 2020 Aug; 158(2):254-255. PubMed ID: 32518014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.
    Anderson RM; Vegvari C; Truscott J; Collyer BS
    Lancet; 2020 Nov; 396(10263):1614-1616. PubMed ID: 33159850
    [No Abstract]   [Full Text] [Related]  

  • 35. A vaccine is not too far for COVID-19.
    Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
    J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
    [No Abstract]   [Full Text] [Related]  

  • 36. Next-generation vaccine platforms for COVID-19.
    van Riel D; de Wit E
    Nat Mater; 2020 Aug; 19(8):810-812. PubMed ID: 32704139
    [No Abstract]   [Full Text] [Related]  

  • 37. Rational Vaccine Design in the Time of COVID-19.
    Burton DR; Walker LM
    Cell Host Microbe; 2020 May; 27(5):695-698. PubMed ID: 32407707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid COVID-19 vaccine development.
    Graham BS
    Science; 2020 May; 368(6494):945-946. PubMed ID: 32385100
    [No Abstract]   [Full Text] [Related]  

  • 39. Advances in skin science enable the development of a COVID-19 vaccine.
    Falo LD
    J Am Acad Dermatol; 2020 Oct; 83(4):1226-1227. PubMed ID: 32485211
    [No Abstract]   [Full Text] [Related]  

  • 40. A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice.
    Lu J; Lu G; Tan S; Xia J; Xiong H; Yu X; Qi Q; Yu X; Li L; Yu H; Xia N; Zhang T; Xu Y; Lin J
    Cell Res; 2020 Oct; 30(10):936-939. PubMed ID: 32801356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.